In post-mortem AD brains, decreased expression of fusion proteins MFN-1, MFN-2, and OPA-1 and increased expression of fission proteins Fis-1 and Drp1 have been reported [12, 19]. This evidence concerns the gene OPA1 and Alzheimer disease.